Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients
- PMID: 22933839
- PMCID: PMC3429358
Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients
Abstract
Purpose: To compare the aqueous humor levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in high myopic eyes and control eyes.
Methods: Aqueous humor samples were collected from 21 highly myopic eyes of 20 patients (high myopia group) and from 30 cataract eyes of 30 patients with no choroidal neovascularization (CNV) or other ocular or systemic diseases (control group). Of the 21 high myopic eyes, 13 had no complications secondary to high myopia (high myopia with no complications group), 3 had posterior staphyloma (high myopia with staphyloma group), and 5 had chorioretinal atrophy (high myopia with chorioretinal atrophy group). The aqueous humor levels of VEGF and PEDF were determined by using commercially available enzyme-linked immunosorbent assay kits.
Results: Aqueous humor levels of VEGF were significantly lower in the high myopia group compared to that in the control group (p<0.001). VEGF levels decreased with an increase in the axial length (p<0.001). PEDF levels tended to be higher in the high myopia group compared to that in the control group; however, the difference was not significant. Three high myopia groups had significantly lower VEGF/PEDF ratios than the control group (p=0.000, 0.002, and 0.005).
Conclusions: Aqueous humor levels of VEGF in the high myopia group were significantly lower than those in the control group. The differing levels of VEGF and PEDF in the high myopia and control groups suggest that high myopia disrupts the VEGF/PEDF balance in retinal pigment epithelium (RPE) cells.
Figures
Similar articles
-
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.Am J Ophthalmol. 2006 Mar;141(3):456-62. doi: 10.1016/j.ajo.2005.10.012. Am J Ophthalmol. 2006. PMID: 16490490 Clinical Trial.
-
Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation.Br J Ophthalmol. 2015 Jul;99(7):1004-8. doi: 10.1136/bjophthalmol-2014-306465. Epub 2015 Mar 13. Br J Ophthalmol. 2015. PMID: 25770144
-
[Vascular endothelial growth factor and pigment epithelium-derived factor in aqueous humor of patients with choroidal neovascularization].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 May;35(3):311-4. doi: 10.3785/j.issn.1008-9292.2006.03.014. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 16764035 Chinese.
-
Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis.Surv Ophthalmol. 2023 Nov-Dec;68(6):1011-1026. doi: 10.1016/j.survophthal.2023.07.006. Epub 2023 Jul 28. Surv Ophthalmol. 2023. PMID: 37517683 Review.
-
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.Expert Opin Biol Ther. 2016 Jul;16(7):873-81. doi: 10.1517/14712598.2016.1167868. Epub 2016 Apr 7. Expert Opin Biol Ther. 2016. PMID: 26985834 Review.
Cited by
-
Aqueous humor protein markers in myopia: a review.Int Ophthalmol. 2024 Feb 7;44(1):21. doi: 10.1007/s10792-024-02942-z. Int Ophthalmol. 2024. PMID: 38324137 Review.
-
Innate immune responsive inflammation in development of progressive myopia.Eye (Lond). 2024 Jan 29. doi: 10.1038/s41433-024-02947-z. Online ahead of print. Eye (Lond). 2024. PMID: 38287111
-
Biomarker Signature in Aqueous Humor Mirrors Lens Epithelial Cell Activation: New Biomolecular Aspects from Cataractogenic Myopia.Biomolecules. 2023 Aug 29;13(9):1328. doi: 10.3390/biom13091328. Biomolecules. 2023. PMID: 37759728 Free PMC article.
-
High VEGF Concentrations Accelerate Human Trabecular Meshwork Fibrosis in a TAZ-Dependent Manner.Int J Mol Sci. 2023 Jun 1;24(11):9625. doi: 10.3390/ijms24119625. Int J Mol Sci. 2023. PMID: 37298577 Free PMC article.
-
Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study.Ophthalmol Sci. 2022 Feb 25;2(2):100130. doi: 10.1016/j.xops.2022.100130. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249687 Free PMC article.
References
-
- Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology. 2003;110:1297–305. - PubMed
-
- Forte R, Cennamo G, Pascotto F, de Crecchio G. En face optical coherence tomography of the posterior pole in high myopia. Am J Ophthalmol. 2008;145:281–8. - PubMed
-
- Gözüm N, Cakir M, Gücukoglu A, Sezen F. Relationship between retinal lesions and axial length, age and sex in high myopia. Eur J Ophthalmol. 1997;7:277–82. - PubMed
-
- Dogru M, Inoue M, Nakamura M, Yamamoto M. Modifying factors related to asymmetric diabetic retinopathy. Eye (Lond) 1998;12:929–33. - PubMed
-
- Janghorbani M, Jones RB, Allison SP. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders. Ophthalmic Epidemiol. 2000;7:225–41. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous